![Martin Hermanus Soeters](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Martin Hermanus Soeters
Directeur/Membre du Conseil chez
CUBIST PHARMACEUTICALS INC
Profil
Martin Hermanus Soeters is currently the Director at Cubist Pharmaceuticals LLC, the Director at Steno Diabetes Center A, and the Member & Head-Europe at the European Federation of Pharmaceutical Industries & Assns.
Previously, he held positions such as Director at Pharmacopeia LLC from 2006 to 2008, Director at Biotechnology Innovation Organization from 2005 to 2007, Director at Pharmaceutical Research & Manufacturers of America from 2004 to 2006, Managing Director at Novo Nordisk SAS from 1992 to 1995, Managing Director at Novo Nordisk Pharma NV from 1992 to 1995, Director at Novo Nordisk Farma Oy, Director at Novo Nordisk Scandinavia AB, Senior Vice President-European Region at Novo Nordisk A, Trustee at HealthCare Institute of New Jersey from 2005 to 2007, President-US at Novo Nordisk Pharmaceutical Industries, Inc. from 2000 to 2011, and Senior Vice President & President-North America at Novo Nordisk, Inc. from 2000 to 2007.
Postes actifs de Martin Hermanus Soeters
| Sociétés | Poste | Début |
|---|---|---|
| CUBIST PHARMACEUTICALS INC | Directeur/Membre du Conseil | 01/09/2006 |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services Operates as a trade association which promotes pharmaceutical discovery and development | Corporate Officer/Principal | - |
Steno Diabetes Center A/S
 Steno Diabetes Center A/S Miscellaneous Commercial ServicesCommercial Services Provides diabetes research laboratory services | Directeur/Membre du Conseil | - |
Anciens postes connus de Martin Hermanus Soeters
| Sociétés | Poste | Fin |
|---|---|---|
Pharmacopeia LLC
 Pharmacopeia LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Directeur/Membre du Conseil | 23/12/2008 |
HealthCare Institute of New Jersey
 HealthCare Institute of New Jersey The HealthCare Institute of New Jersey is a trade association representing research-based biopharmaceutical, medical device, and diagnostic companies. The private company is based in Bridgewater, NJ. It advocates for policies that promote innovation, patient access to advanced medical products, and job creation within the life sciences sector. The organization collaborates with government, academia, and stakeholders to foster an innovation ecosystem and raise awareness of the industry’s clinical, economic, and social impact. It emphasizes corporate social responsibility, including commitments to philanthropy, environmental sustainability, ethical practices, and community engagement. The institute leads initiatives in diversity, equity, and inclusion, aiming to transform corporate culture, diversify supply chains, and address health inequities. It provides patient advocacy and assistance programs, such as the rx4nj partnership and njsave, which connect patients to prescription assistance and other support programs. Christine Buteas has been the CEO of the company since 2024. | Directeur/Membre du Conseil | 01/01/2007 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Directeur/Membre du Conseil | 01/01/2007 |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Corporate Officer/Principal | 01/01/2007 |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Directeur/Membre du Conseil | 01/01/2006 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
76
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Pharmacopeia LLC
Pharmacopeia LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services Operates as a trade association which promotes pharmaceutical discovery and development | Commercial Services |
HealthCare Institute of New Jersey
HealthCare Institute of New Jersey The HealthCare Institute of New Jersey is a trade association representing research-based biopharmaceutical, medical device, and diagnostic companies. The private company is based in Bridgewater, NJ. It advocates for policies that promote innovation, patient access to advanced medical products, and job creation within the life sciences sector. The organization collaborates with government, academia, and stakeholders to foster an innovation ecosystem and raise awareness of the industry’s clinical, economic, and social impact. It emphasizes corporate social responsibility, including commitments to philanthropy, environmental sustainability, ethical practices, and community engagement. The institute leads initiatives in diversity, equity, and inclusion, aiming to transform corporate culture, diversify supply chains, and address health inequities. It provides patient advocacy and assistance programs, such as the rx4nj partnership and njsave, which connect patients to prescription assistance and other support programs. Christine Buteas has been the CEO of the company since 2024. | |
Novo Nordisk Pharmaceutical Industries, Inc.
 Novo Nordisk Pharmaceutical Industries, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparations | Health Technology |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Health Technology |
Novo Nordisk SAS
 Novo Nordisk SAS Pharmaceuticals: MajorHealth Technology Manufactures and wholesales diabetes drugs | Health Technology |
Novo Nordisk Pharma NV SA
 Novo Nordisk Pharma NV SA Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals and treatments for people with chronic illness | Health Technology |
Novo Nordisk Farma Oy
 Novo Nordisk Farma Oy Medical/Nursing ServicesHealth Services Provides diabetes care services | Health Services |
Novo Nordisk Scandinavia AB
 Novo Nordisk Scandinavia AB Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products and services | Health Technology |
Steno Diabetes Center A/S
Steno Diabetes Center A/S Miscellaneous Commercial ServicesCommercial Services Provides diabetes research laboratory services | Commercial Services |
Choisissez Zonebourse 
